FI Works founder Keith Henkel says community banks and credit unions have the data, but lack a way to turn a warning sign into a call to the right person.
FI Works, which builds a relationship intelligence and engagement platform for community banks and credit unions, has launched Signals, a feature that uses machine learning to spot households likely to add a product, take up digital services or leave the
Netcall's Pol Brouckaert argues that as AI makes fake documents easier to produce, checks on whether evidence can be trusted must sit inside workflows.
Businesses have spent years automating the processing of claims, applications and supporting documents.
N26 is partnering with Franklin Templeton to launch a digital retirement account in Germany, offering ETF investments and government-backed incentives from January 2027.
N26 today announced the upcoming launch of its new private retirement account (Altersvorsorgedepot) in Germany.
Dublin-based ID-Pal brings KYC and KYB capabilities to ThirdEye's AML platform as AI-accelerated fraud reshapes compliance in Australia and New Zealand.
Dublin-based ID-Pal brings KYC and KYB capabilities to ThirdEye's AML platform as AI-accelerated fraud reshapes compliance in Australia and New Zealand.
Flowes launches a PayFac-as-a-Service proposition letting software platforms own the merchant payments experience without building core infrastructure.
Flowes launches a PayFac-as-a-Service proposition letting software platforms own the merchant payments experience without building core infrastructure.
Chang Li of FinCity.Tokyo explains why global fintech startups are choosing Tokyo, from government support and open corporations to agentic AI and local partnerships.
Mark Walker, editorial director of the FinTech Times, interviewed Chang Li about Tokyo's growth as a fintech hub.
Nasdaq-listed Solmate says it plans to resell UAE-sourced GPU capacity for AI training and inference, with payment options including Solana stablecoins.
The EMA's advisory committee recommended secukinumab for patients aged 12 and over with moderate to severe hidradenitis suppurativa, with an EC decision expected within